title: Paraneoplastic dermatomyositis triggered and exacerbated by oral 5-fluorouracil administration.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Kawachi
authors.forename: Yumiko
authors.initials: Y
authors.lastname: Koike
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Kano
authors.forename: Junichi
authors.initials: J
authors.lastname: Furuta
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Fujisawa
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Ishii
authors.forename: Takenori
authors.initials: T
authors.lastname: Takahashi
authors.forename: Fujio
authors.initials: F
authors.lastname: Otsuka
mesh_terms: D000284:Administration, Oral; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D003882:Dermatomyositis / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D003937:Diagnosis, Differential; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010257:Paraneoplastic Syndromes / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D013274:Stomach Neoplasms / Q000188:drug therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil